Alla Rutstein Bobbitt is a healthcare, pharmaceutical, and biodefense policy expert and biomedical writer and editor with nearly 20 years of public and private sector experience. Her diverse background has provided her with a unique inside and outside perspective on pharmaceutical and biotech R&D, manufacturing, and regulation, with an emphasis on complex issue analysis and problem-solving. Alla’s experience includes seven years as a policy analyst specializing in medical countermeasures at the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR); five years as a reporter (FDA/regulatory beat) and contributing editor for the premier prescription pharmaceutical and biotechnology newsletter “The Pink Sheet”; and two years as managing editor of a comprehensive, international drug and biologic development database. Her work has involved leading subject matter expert groups; interviewing senior officials, reporting on and analyzing clinical research outcomes and regulatory strategies; authoring options papers and reports; and making high-level policy recommendations to senior leadership. Alla has an M.A. in psychology from American University, with a focus on neuropsychology. She is also bilingual in Russian-English and has substantial interpreting and international experience.